Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025

ラテラルフローアッセイ(LFA)の世界市場予測(~2025):用途別、製品別、技術別、エンドユーザー別

◆タイトル:Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025
◆商品コード:MD 4158
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年11月30日
◆ページ数:333
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はラテラルフローアッセイ(LFA)の世界市場が2020年82億ドルから2025年102億ドルまで、年平均4.5%成長すると予想しています。本市場調査資料では、ラテラルフローアッセイ(LFA)の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業動向、製品別(キット・試薬、ラテラルフローリーダー)分析、用途別(臨床検査、獣医検査、食品安全・環境検査、医薬品開発・品質検査)分析、技術別(サンドイッチアッセイ、競合アッセイ、マルチプレックス検出アッセイ)分析、サンプル種類別(血液サンプル、尿サンプル、唾液サンプル、その他)分析、エンドユーザー別(病院・クリニック、診断ラボ、在宅医療、製薬・バイオテクノロジー企業、その他)分析、地域別分析、競争状況、企業評価マトリックス・企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業動向
・ラテラルフローアッセイ(LFA)の世界市場規模:製品別(キット・試薬、ラテラルフローリーダー)
・ラテラルフローアッセイ(LFA)の世界市場規模:用途別(臨床検査、獣医検査、食品安全・環境検査、医薬品開発・品質検査)
・ラテラルフローアッセイ(LFA)の世界市場規模:技術別(サンドイッチアッセイ、競合アッセイ、マルチプレックス検出アッセイ)
・ラテラルフローアッセイ(LFA)の世界市場規模:サンプル種類別(血液サンプル、尿サンプル、唾液サンプル、その他)
・ラテラルフローアッセイ(LFA)の世界市場規模:エンドユーザー別(病院・クリニック、診断ラボ、在宅医療、製薬・バイオテクノロジー企業、その他)
・ラテラルフローアッセイ(LFA)の世界市場規模:地域別
・競争状況
・企業評価マトリックス・企業情報

“The global lateral flow assays market is projected to reach USD 10.2 billion by 2025 from USD 8.2 billion in 2020, at a CAGR of 4.5% during the forecast period.”
The growing prevalence of infectious diseases globally, increasing aging population, growing demand for point-of-care and home-based lateral flow assay devices, and increasing demand in food and environment safety and veterinary diagnostics industry are the major factors driving the growth of this market. On the other hand, the reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key factors restraining the growth of the market in the forecast period.

“The kits and reagents segment holds the highest market share, by product, in the forecast period.”
On the basis of product, the lateral flow assays market is broadly segmented into kits & reagents and lateral flow readers. Lateral flow readers are further segmented into digital/handheld readers, benchtop readers and mobile/smartphone readers. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, growing burden of chronic diseases, increasing use of lateral flow kits in home care, and the convenience and ease of use of kits & reagents.

“Wide applications of lateral flow assays in food safety and environment testing promote the growth of this segment in the forecast period.”
Based on applications, the lateral flow assays market is broadly segmented into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The food safety & environment testing segment is projected to register the highest growth rate in the lateral flow assays market, by an application during the forecast period. This can be attributed to lateral flow assays emerging as simple and rapid alternatives to traditional methods for the detection of foodborne pathogens and contaminants. In case of environment testing, lateral flow assays finding wide applications due to their ability to handle a wide variety of samples and perform many sample-handling tasks, such as filtration, concentration, and removal of cross-reactive elements.

“In the lateral flow assay kits & reagents by technique segment,, sandwich assays holds the highest market share.”
On the basis of technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. Sandwich assays holds the highest share in the lateral flow assays market. The large share of this segment can be attributed to the better assay sensitivity and specificity associated with sandwich assays as well as its extensive application in the measurement of critical analytes (such as cardiac and hepatitis markers).

“By sample type, the Other Samples segment is growing at the fastest rate in the forecast period.”
Based on sample type, the lateral flow assays market for clinical testing applications is segmented into blood, urine, saliva, and other samples. In this segment, Other Samples is projected to register the highest growth rate in the lateral flow assays market for clinical testing applications segment during the forecast period. The high growth rate of this segment can be attributed to increase in R&D for lateral flow diagnostic testing and the need for more specific disease testing.

“North American region holds the highest market share in the lateral flow assays market.”
North America is expected to account for the largest share of the global lateral flow assays market in 2019. The large share of the North American region is due to the lucrative growth opportunities the region offers due to the presence of several large hospitals and health systems, changing regulations, and the rising geriatric population in the country. A vast majority of global players are also based in the US, owing to which the country is a center for innovation in the lateral flow assays market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–25%, and Tier 3–45%
• By Designation: C-level–40%, Director Level–35%, and Others–25%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, Middle East & Africa – 7%

The prominent players in the global lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), Merck KGaA (Germany), Abcam plc (UK), Surmodics IVD (US), Chembio Diagnostic Systems, Inc. (US), OraSure Technologies (US), DCN Diagnostics (US), Polysciences, Inc. (US), Abingdon Health (UK), BioPorto Diagnostics A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), Scienion AG (Germany), Senova GmbH (Germany), and Access Bio, Inc. (US).

Research Coverage:
The report analyzes the market for various lateral flow assays market and their adoption pattern. It aims at estimating the market size and future growth potential of the global lateral flow assays market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global lateral flow assays market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global lateral flow assays market
• Market Development: Comprehensive information on the lucrative emerging regions by products, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global lateral flow assays market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global lateral flow assays market

【レポートの目次】

1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET 44
1.3 MARKET SCOPE 45
1.3.1 MARKETS COVERED 45
1.3.2 YEARS CONSIDERED FOR THE STUDY 46
1.4 CURRENCY 46
1.4.1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 46
1.5 LIMITATIONS 46
1.6 STAKEHOLDERS 47
1.7 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH APPROACH 49
2.1.1 RESEARCH DESIGN 49
2.1.2 SECONDARY DATA 49
2.1.2.1 Key data from secondary sources 50
2.1.3 PRIMARY DATA 51
2.1.3.1 Primary sources 51
2.1.3.2 Key data from primary sources 52
2.1.3.3 Breakdown of primaries 52
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.2 MARKET SIZE ESTIMATION 53
FIGURE 2 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019) 53
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019) 54
FIGURE 4 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019) 54
FIGURE 5 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2019) 55
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2019) 56
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE LATERAL FLOW ASSAYS MARKET (2020–2025) 57
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 8 DATA TRIANGULATION METHODOLOGY 58
2.4 MARKET SHARE ESTIMATION 59
2.5 ASSUMPTIONS FOR THE STUDY 59
2.6 COVID-19 HEALTH ASSESSMENT 60
2.7 COVID-19 ECONOMIC ASSESSMENT 60
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 61
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 61
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET 63
3 EXECUTIVE SUMMARY 64
FIGURE 11 LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 64
FIGURE 12 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,
2020 VS. 2025 (USD MILLION) 65
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 65
FIGURE 14 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2020 VS. 2025 (USD MILLION) 66
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 67
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET 68
4 PREMIUM INSIGHTS 69
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 69
FIGURE 17 RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET 69
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 70
FIGURE 18 APAC TO REGISTER THE HIGHEST CAGR OF 7.0% DURING THE FORECAST PERIOD 70
4.3 LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
FIGURE 20 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 72
5.2.1 MARKET DRIVERS 72
5.2.1.1 High prevalence of infectious diseases across the globe 72
FIGURE 21 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE 73
TABLE 1 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2019) 73
5.2.1.2 Rapidly increasing geriatric population 74
FIGURE 22 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (MILLION) 74
FIGURE 23 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (MILLION) 74
5.2.1.3 Growing usage of home-based lateral flow assay devices 75
5.2.1.4 Growing demand for point-of-care testing 75
5.2.1.5 Need for rapid diagnostic testing for COVID-19 76
FIGURE 24 NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION) 76
5.2.2 MARKET RESTRAINTS 76
5.2.2.1 Reluctance towards changing existing diagnostic practices 76
5.2.2.2 Lower accuracy of lateral flow assay tests 77
5.2.3 MARKET OPPORTUNITIES 77
5.2.3.1 Evolving applications of lateral flow assays 77
TABLE 2 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 77
5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry 78
5.2.4 CHALLENGES 78
5.2.4.1 Limited reimbursements for lateral flow assay products 78
5.2.4.2 Difficulties in procuring quality raw materials for the development of lateral flow assay tests 79
5.3 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 3 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 80
5.3.1 THREAT FROM NEW ENTRANTS 80
5.3.2 THREAT FROM SUBSTITUTES 81
5.3.3 BARGAINING POWER OF SUPPLIERS 81
5.3.4 BARGAINING POWER OF BUYERS 81
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.4 AVERAGE SELLING PRICE TREND 82
TABLE 4 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION,
2015 VS. 2020 82
5.5 VALUE CHAIN ANALYSIS 82
FIGURE 25 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2019) 83
5.6 ECOSYSTEM MAP 83
FIGURE 26 ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2019) 83
5.7 TECHNOLOGY ANALYSIS 85
5.7.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 85
5.7.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS) 85
5.8 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET 85
6 INDUSTRY INSIGHTS 87
6.1 INTRODUCTION 87
6.2 INDUSTRY TRENDS 87
6.2.1 INTEGRATION OF MICROFLUIDIC TECHNOLOGY IN LATERAL FLOW ASSAYS 87
6.2.2 DEMAND FOR QUANTITATIVE RESULTS 88
TABLE 5 MANUFACTURERS AND MODELS OF OPTICAL DETECTORS FOR RECORDING IMMUNOCHROMATOGRAPHY RESULTS 88
TABLE 6 EXAMPLES OF SMARTPHONE/MOBILE PHONE-BASED QUANTITATIVE LATERAL FLOW ASSAYS AND THEIR TARGET ANALYTES 89
6.2.3 RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS 89
6.2.4 NANOPARTICLE-BASED LATERAL FLOW ASSAYS 90
6.3 REGULATORY ANALYSIS 90
TABLE 7 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 90
6.3.1 NORTH AMERICA 90
6.3.2 EUROPE 91
6.3.3 ASIA 92
6.3.3.1 India 92
6.3.3.2 China 92
6.3.3.3 Japan 92
6.4 COMPONENT ANALYSIS FOR LATERAL FLOW ASSAY KITS 92
6.4.1 MEMBRANES 92
6.4.1.1 Nitrocellulose membranes 93
6.4.1.2 Other membranes 93
6.4.2 PADS 94
6.4.2.1 Conjugate pads 94
6.4.2.2 Absorbent pads 94
7 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 95
7.1 INTRODUCTION 96
TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 96
7.2 KITS & REAGENTS 96
7.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET 96
TABLE 9 LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 97
7.3 LATERAL FLOW READERS 97
TABLE 10 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET 97
TABLE 11 LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 12 LATERAL FLOW READERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 99
7.3.1 DIGITAL/HANDHELD READERS 99
7.3.1.1 Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market 99
TABLE 13 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 100
7.3.2 BENCHTOP READERS 100
7.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market 100
TABLE 14 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 101
7.3.3 MOBILE/SMARTPHONE READERS 101
7.3.3.1 Low cost, convenience, and user-friendliness are major factors driving the growth of the mobile/smartphone readers market 101
8 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 102
8.1 INTRODUCTION 103
TABLE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 103
8.2 CLINICAL TESTING 103
TABLE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 17 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 104
8.2.1 INFECTIOUS DISEASE TESTING 105
TABLE 18 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2018–2025 (USD MILLION) 105
TABLE 19 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 106
8.2.1.1 Mosquito-borne diseases 106
8.2.1.1.1 Increasing incidence of dengue is driving the growth of the lateral flow assays market for mosquito-borne diseases 106
TABLE 20 MAJOR PRODUCTS: DENGUE TESTING 107
TABLE 21 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 108
8.2.1.2 COVID-19 108
8.2.1.2.1 The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests 108
TABLE 22 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS (2020) 109
TABLE 23 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY,
2018–2025 (USD MILLION) 110
8.2.1.3 Influenza 110
8.2.1.3.1 Growing prevalence of influenza globally is expected to boost the growth of the influenza testing market 110
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY,
2018–2025 (USD MILLION) 111
8.2.1.4 Sexually transmitted infections 111
TABLE 25 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 26 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2018–2025 (USD MILLION) 113
8.2.1.4.1 HIV 113
8.2.1.4.1.1 Growing awareness about HIV POC testing is one of the major factors driving market growth 113
FIGURE 27 PATIENTS TREATED FOR HIV GLOBALLY, 2005–2019 114
TABLE 27 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY,
2018–2025 (USD MILLION) 115
8.2.1.4.2 HPV 115
8.2.1.4.2.1 Rising adoption of HPV testing to drive the market during the forecast period 115
TABLE 28 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY,
2018–2025 (USD MILLION) 116
8.2.1.4.3 Chlamydia 116
8.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients is driving the growth of this segment 116
TABLE 29 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2018–2025 117
8.2.1.4.4 Gonorrhea 117
8.2.1.4.4.1 Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period 117
TABLE 30 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY,
2018–2025 (USD MILLION) 118
8.2.1.4.5 Syphilis 119
8.2.1.4.5.1 Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing 119
TABLE 31 NUMBER OF CASES OF SYPHILIS, BY COUNTRY, 2011–2018 119
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY,
2018–2025 (USD MILLION) 120
8.2.1.4.6 Other sexually transmitted infections 120
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2018–2025 (USD MILLION) 121
8.2.1.5 Hepatitis 121
8.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market 121
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY,
2018–2025 (USD MILLION) 122
8.2.1.6 Tuberculosis 122
8.2.1.6.1 Rising prevalence of the disease and a growing focus on early diagnosis and treatment of tuberculosis is expected to drive this market 122
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY,
2018–2025 (USD MILLION) 123
8.2.1.7 Other infectious diseases 123
TABLE 36 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 124
8.2.2 CARDIAC MARKER TESTING 125
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 38 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 126
8.2.2.1 Troponin I and T testing 126
8.2.2.1.1 Introduction of high-sensitivity troponin assays to drive this market during the forecast period 126
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 127
8.2.2.2 CK-MB testing 127
8.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive this market 127
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY,
2018–2025 (USD MILLION) 128
8.2.2.3 BNP and NT-proBNP testing 129
8.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market 129
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 129
8.2.2.4 Myoglobin testing 130
8.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market 130
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 130
8.2.2.5 D-Dimer testing 131
8.2.2.5.1 Rising incidence of cardiovascular diseases globally is expected to drive the market for D-dimer tests 131
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 131
8.2.2.6 Other cardiac markers 132
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS,
BY COUNTRY, 2018–2025 (USD MILLION) 132
8.2.3 PREGNANCY & FERTILITY TESTING 133
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 134
8.2.3.1 Pregnancy testing 134
8.2.3.1.1 Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period 134
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 135
8.2.3.2 Fertility testing 135
8.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits 135
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 136
8.2.4 CHOLESTEROL TESTING/LIPID PROFILES 136
8.2.4.1 Growing prevalence of obesity and CVD is the key factor driving market growth 136
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILES, BY COUNTRY, 2018–2025 (USD MILLION) 137
8.2.5 DRUGS-OF-ABUSE TESTING 137
8.2.5.1 Technological advancements and growing focus on workplace drug testing are driving market growth 137
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING,
BY COUNTRY, 2018–2025 (USD MILLION) 138
8.2.6 OTHER CLINICAL TESTS 139
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2018–2025 (USD MILLION) 139
8.3 VETERINARY DIAGNOSTICS 139
8.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 139
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,
BY COUNTRY, 2018–2025 (USD MILLION) 140
8.4 FOOD SAFETY & ENVIRONMENT TESTING 141
8.4.1 HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 141
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 142
8.5 DRUG DEVELOPMENT & QUALITY TESTING 142
8.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET 142
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2018–2025 (USD MILLION) 143
8.6 COVID-19 IMPACT ON THE LATERAL FLOW ASSAY APPLICATION MARKET 143
9 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE 144
9.1 INTRODUCTION 145
TABLE 55 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 145
9.2 SANDWICH ASSAYS 145
9.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTING TO THE LARGEST SHARE OF THIS SEGMENT 145
TABLE 56 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 146
9.3 COMPETITIVE ASSAYS 147
9.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH 147
TABLE 57 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 147
9.4 MULTIPLEX DETECTION ASSAYS 148
9.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET 148
TABLE 58 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 148
10 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE 149
10.1 INTRODUCTION 150
TABLE 59 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 150
10.2 BLOOD SAMPLES 150
10.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT 150
TABLE 60 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2018–2025 (USD MILLION) 151
10.3 URINE SAMPLES 151
10.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET 151
TABLE 61 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,
BY COUNTRY, 2018–2025 (USD MILLION) 152
10.4 SALIVA SAMPLES 152
10.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH 152
TABLE 62 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2018–2025 (USD MILLION) 153
10.5 OTHER SAMPLES 153
TABLE 63 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,
BY COUNTRY, 2018–2025 (USD MILLION) 154
11 LATERAL FLOW ASSAYS MARKET, BY END USER 155
11.1 INTRODUCTION 156
TABLE 64 LATERAL FLOW ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION) 156
11.2 HOSPITALS & CLINICS 156
11.2.1 INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS 156
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 157
11.3 DIAGNOSTIC LABORATORIES 157
11.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING—A KEY FACTOR DRIVING MARKET GROWTH 157
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2018–2025 (USD MILLION) 158
11.4 HOME CARE SETTINGS 158
11.4.1 GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE 158
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2025 (USD MILLION) 159
11.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 160
11.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES 160
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 160
11.6 OTHER END USERS 161
TABLE 69 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION) 161
12 LATERAL FLOW ASSAYS MARKET, BY REGION 162
12.1 INTRODUCTION 163
FIGURE 28 US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD 163
TABLE 70 LATERAL FLOW ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 164
12.2 NORTH AMERICA 164
TABLE 71 NORTH AMERICA: MACROECONOMIC INDICATORS 165
FIGURE 29 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 165
TABLE 72 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 166
TABLE 73 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 166
TABLE 74 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 166
TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 167
TABLE 76 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 167
TABLE 77 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 168
TABLE 78 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 168
TABLE 79 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 169
TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 169
TABLE 81 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2018–2025 (USD MILLION) 169
TABLE 82 NORTH AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,
BY SAMPLE TYPE, 2018–2025 (USD MILLION) 170
TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 170
12.2.1 US 170
12.2.1.1 The US accounts for the largest share of the lateral flow assays market in North America 170
TABLE 84 US: MACROECONOMIC INDICATORS 171
TABLE 85 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 171
TABLE 86 US: LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 87 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 172
TABLE 88 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 89 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2018–2025 (USD MILLION) 173
TABLE 90 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 91 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 92 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 93 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 174
TABLE 94 US: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 175
TABLE 95 US: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 USD MILLION) 175
12.2.2 CANADA 175
12.2.2.1 Availability of research funding and implementation of favorable government initiatives are driving the market in Canada 175
TABLE 96 CANADA: MACROECONOMIC INDICATORS 176
TABLE 97 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 176
TABLE 98 CANADA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 177
TABLE 99 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 177
TABLE 100 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 177
TABLE 101 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 178
TABLE 102 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2025 (USD MILLION) 178
TABLE 103 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 179
TABLE 104 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 179
TABLE 105 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 179
TABLE 106 CANADA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 180
TABLE 107 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 180
12.3 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN NORTH AMERICA 180
12.4 EUROPE 181
TABLE 108 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 181
TABLE 109 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 181
TABLE 110 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 182
TABLE 111 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 182
TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 182
TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 183
TABLE 114 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 183
TABLE 115 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 184
TABLE 116 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 184
TABLE 117 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 184
TABLE 118 EUROPE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 185
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 185
12.4.1 GERMANY 185
12.4.1.1 Growing number of the POC diagnostics centers to drive the demand for lateral flow assays in Germany 185
TABLE 120 GERMANY: MACROECONOMIC INDICATORS 186
TABLE 121 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 186
TABLE 122 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 186
TABLE 123 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 187
TABLE 124 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 187
TABLE 125 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 188
TABLE 126 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 188
TABLE 127 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 189
TABLE 128 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 189
TABLE 129 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2018–2025 (USD MILLION) 189
TABLE 130 GERMANY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 190
TABLE 131 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 190

12.4.2 FRANCE 190
12.4.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 190
TABLE 132 FRANCE: MACROECONOMIC INDICATORS 191
TABLE 133 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 191
TABLE 134 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 135 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 192
TABLE 136 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 192
TABLE 137 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 193
TABLE 138 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 193
TABLE 139 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 194
TABLE 140 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 194
TABLE 141 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 194
TABLE 142 FRANCE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 195
TABLE 143 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 195
12.4.3 UK 195
12.4.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK 195
TABLE 144 UK: MACROECONOMIC INDICATORS 196
TABLE 145 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 196
TABLE 146 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 147 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 197
TABLE 148 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 197
TABLE 149 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2018–2025 (USD MILLION) 198
TABLE 150 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 198
TABLE 151 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 199
TABLE 152 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 199
TABLE 153 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 199
TABLE 154 UK: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 200
TABLE 155 UK: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 200
12.4.4 ITALY 200
12.4.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 200
TABLE 156 ITALY: MACROECONOMIC INDICATORS 201
TABLE 157 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 201
TABLE 158 ITALY: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 201
TABLE 159 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 202
TABLE 160 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 202
TABLE 161 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 203
TABLE 162 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 203
TABLE 163 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 204
TABLE 164 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 204
TABLE 165 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 204
TABLE 166 ITALY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 205
TABLE 167 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 205
12.4.5 SPAIN 205
12.4.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 205
TABLE 168 SPAIN: MACROECONOMIC INDICATORS 206
TABLE 169 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 206
TABLE 170 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 206
TABLE 171 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 207
TABLE 172 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 207
TABLE 173 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 208
TABLE 174 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 208
TABLE 175 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 209
TABLE 176 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 209
TABLE 177 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 209
TABLE 178 SPAIN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 210
TABLE 179 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 210
12.4.6 REST OF EUROPE 210
TABLE 180 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 211
TABLE 181 ROE: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 211
TABLE 182 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 211
TABLE 183 ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 212
TABLE 184 ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2018–2025 (USD MILLION) 212
TABLE 185 ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 213
TABLE 186 ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 213
TABLE 187 ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 213
TABLE 188 ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 214
TABLE 189 ROE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 214
TABLE 190 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 214
12.5 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN EUROPE 215
12.6 ASIA PACIFIC 215
FIGURE 30 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 216
TABLE 191 APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY
, 2018–2025 (USD MILLION) 216
TABLE 192 APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 217
TABLE 193 APAC: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 217
TABLE 194 APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 217
TABLE 195 APAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 218
TABLE 196 APAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 218
TABLE 197 APAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 219
TABLE 198 APAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 219
TABLE 199 APAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 219
TABLE 200 APAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 220
TABLE 201 APAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 220
TABLE 202 APAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 220
12.6.1 CHINA 221
12.6.1.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development is expected to drive the market growth in China 221
TABLE 203 CHINA: MACROECONOMIC INDICATORS 221
TABLE 204 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 222
TABLE 205 CHINA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 222
TABLE 206 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 222
TABLE 207 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 223
TABLE 208 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 223
TABLE 209 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 224
TABLE 210 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 224
TABLE 211 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 224
TABLE 212 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 225
TABLE 213 CHINA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 225
TABLE 214 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 225
12.6.2 JAPAN 226
12.6.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assays market in Japan 226
TABLE 215 JAPAN: MACROECONOMIC INDICATORS 226
TABLE 216 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 227
TABLE 217 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 227
TABLE 218 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 227
TABLE 219 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 228
TABLE 220 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 228
TABLE 221 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 229
TABLE 222 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 229
TABLE 223 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 229
TABLE 224 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 230
TABLE 225 JAPAN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 230
TABLE 226 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 230
12.6.3 INDIA 231
12.6.3.1 Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels to propel the growth of this market 231
TABLE 227 INDIA: MACROECONOMIC INDICATORS 231
TABLE 228 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 231
TABLE 229 INDIA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 232
TABLE 230 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 232
TABLE 231 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 232
TABLE 232 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 233
TABLE 233 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 233
TABLE 234 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 234
TABLE 235 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 234
TABLE 236 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 234
TABLE 237 INDIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 235
TABLE 238 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 235
12.6.4 AUSTRALIA 235
12.6.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assays market 235
TABLE 239 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 236
TABLE 240 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 236
TABLE 241 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 236
TABLE 242 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 237
TABLE 243 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 237
TABLE 244 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 245 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 246 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 247 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2018–2025 (USD MILLION) 239
TABLE 248 AUSTRALIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 239
TABLE 249 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 239
12.6.5 REST OF ASIA PACIFIC 240
TABLE 250 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 240
TABLE 251 ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 240
TABLE 252 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 241
TABLE 253 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 241
TABLE 254 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 242
TABLE 255 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 242
TABLE 256 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 243
TABLE 257 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 243
TABLE 258 ROAPAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 243
TABLE 259 ROAPAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 244
TABLE 260 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 244
12.7 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE ASIA PACIFIC 244
12.8 LATIN AMERICA 245
TABLE 261 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 245
TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 245
TABLE 263 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 246
TABLE 264 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 246
TABLE 265 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 246
TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 247
TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 247
TABLE 268 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 248
TABLE 269 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 248
TABLE 270 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2018–2025 (USD MILLION) 248
TABLE 271 LATIN AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,
BY SAMPLE TYPE, 2018–2025 (USD MILLION) 249
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 249
12.8.1 BRAZIL 249
12.8.1.1 High private healthcare expenditure and increasing geriatric population driving the growth of the lateral flow assays market in the country 249
TABLE 273 BRAZIL: MACROECONOMIC INDICATORS 250
TABLE 274 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 250
TABLE 275 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 250
TABLE 276 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 251
TABLE 277 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 251
TABLE 278 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 252
TABLE 279 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 252
TABLE 280 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2018–2025 (USD MILLION) 253
TABLE 281 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 253
TABLE 282 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 253
TABLE 283 BRAZIL: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 254
TABLE 284 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 254
12.8.2 MEXICO 254
12.8.2.1 High prevalence of obesity and related chronic diseases to boost the growth of the lateral flow assays market in the forecast period 254
TABLE 285 MEXICO: MACROECONOMIC INDICATORS 255
TABLE 286 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 255
TABLE 287 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 255
TABLE 288 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 256
TABLE 289 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 256
TABLE 290 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 257
TABLE 291 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 257
TABLE 292 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 258
TABLE 293 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 258
TABLE 294 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 258
TABLE 295 MEXICO: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 259
TABLE 296 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 259
12.8.3 REST OF LATIN AMERICA 259
TABLE 297 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 260
TABLE 298 ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 260
TABLE 299 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 260
TABLE 300 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 261
TABLE 301 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 261
TABLE 302 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 262
TABLE 303 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION) 262
TABLE 304 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 262
TABLE 305 ROLATAM: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 263
TABLE 306 ROLATAM: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 263
TABLE 307 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 263
12.9 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN LATIN AMERICA 264
12.10 MIDDLE EAST & AFRICA 264
12.10.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS 264
TABLE 308 AFRICA: MACROECONOMIC INDICATORS 265
TABLE 309 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 265
TABLE 310 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 265
TABLE 311 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 20180–2025 (USD MILLION) 266
TABLE 312 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 266
TABLE 313 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 267
TABLE 314 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 267
TABLE 315 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2025 (USD MILLION) 268
TABLE 316 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION) 268
TABLE 317 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 268
TABLE 318 MIDDLE EAST & AFRICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 269
TABLE 319 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION) 269
12.11 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE MIDDLE EAST & AFRICA 269
13 COMPETITIVE LANDSCAPE 270
13.1 INTRODUCTION 270
FIGURE 31 KEY DEVELOPMENTS IN THE GLOBAL LATERAL FLOW ASSAYS MARKET, 2018–2020 270
FIGURE 32 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES DOMINATED THE MARKET BETWEEN 2018 TO 2020 271
13.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 271
FIGURE 33 TOP MARKET PLAYERS DOMINATE THE LATERAL FLOW ASSAYS MARKET 271
13.3 PRODUCT BENCHMARKING 272
FIGURE 34 PRODUCT PORTFOLIO ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019) 273
13.4 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 274
FIGURE 35 GEOGRAPHIC REVENUE MIX: LATERAL FLOW ASSAYS MARKET (2019) 274
13.5 COMPETITIVE ASSESSMENT OF THE R&D EXPENDITURE 275
FIGURE 36 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET, 2017 VS. 2019 275
13.6 COMPETITIVE SITUATIONS AND TRENDS 275
13.6.1 PRODUCT LAUNCHES 275
TABLE 320 PRODUCT LAUNCHES 275
13.6.2 EXPANSIONS 276
TABLE 321 EXPANSIONS 276
13.6.3 ACQUISITIONS 277
TABLE 322 ACQUISITIONS 277
13.6.4 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 278
TABLE 323 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 278
14 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 280
14.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 280
14.2 LATERAL FLOW ASSAYS MARKET SHARE (2019) 280
FIGURE 37 LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER (2019) 280
14.3 COMPETITIVE LEADERSHIP MAPPING 280
14.3.1 STARS 281
14.3.2 EMERGING LEADERS 281
14.3.3 PERVASIVE PLAYERS 281
14.3.4 PARTICIPANTS 281
FIGURE 38 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019 282
14.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2019) 282
14.4.1 PROGRESSIVE COMPANIES 282
14.4.2 DYNAMIC COMPANIES 283
14.4.3 STARTING BLOCKS 283
14.4.4 RESPONSIVE COMPANIES 283
FIGURE 39 LATERAL FLOW ASSAYS MARKET: START-UP COMPANY EVALUATION MATRIX, 2019 283
14.5 COMPANY PROFILES 284
(Business overview, Products offered, Recent developments, SWOT analysis and MNM view)*
14.5.1 ABBOTT LABORATORIES 284
FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 284
14.5.2 F. HOFFMANN-LA ROCHE AG 290
FIGURE 41 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019) 290
14.5.3 DANAHER CORPORATION 294
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 294
14.5.4 SIEMENS AG 298
14.5.5 BECTON, DICKINSON AND COMPANY 302
14.5.6 BIOMÉRIEUX SA 306
14.5.7 BIO-RAD LABORATORIES, INC. 309
14.5.8 THERMO FISHER SCIENTIFIC INC. 311
14.5.9 QIAGEN N.V. 315
14.5.10 PERKINELMER INC. 317
FIGURE 49 PERKINELMER INC.: COMPANY SNAPSHOT (2019) 317
14.5.11 HOLOGIC INC. 320
FIGURE 50 HOLOGIC, INC.: COMPANY SNAPSHOT (2019) 320
14.5.12 QUIDEL CORPORATION 322
FIGURE 51 QUIDEL CORPORATION: COMPANY SNAPSHOT (2019) 322
14.5.13 MERCK KGAA 326
FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2019) 326
14.5.14 ABCAM PLC 328
FIGURE 53 ABCAM PLC: COMPANY SNAPSHOT (2019) 328
14.5.15 SURMODICS IVD 330
FIGURE 54 SURMODICS IVD: COMPANY SNAPSHOT (2019) 330
14.5.16 CHEMBIO DIAGNOSTIC SYSTEMS, INC. 331
FIGURE 55 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: COMPANY SNAPSHOT (2019) 331
14.5.17 ORASURE TECHNOLOGIES 333
FIGURE 56 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2019) 333
14.5.18 DCN DIAGNOSTICS 335
14.5.19 POLYSCIENCES, INC. 335
14.5.20 ABINGDON HEALTH 336
*Details on Business overview, Products offered, Recent developments, SWOT analysis and MNM view might not be captured in case of unlisted companies.
15 APPENDIX 337
15.1 INSIGHTS FROM INDUSTRY EXPERTS 337
15.2 DISCUSSION GUIDE 338
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 343
15.4 AVAILABLE CUSTOMIZATIONS 345
15.5 RELATED REPORTS 345
15.6 AUTHOR DETAILS 346

★調査レポート[ラテラルフローアッセイ(LFA)の世界市場予測(~2025):用途別、製品別、技術別、エンドユーザー別] ( Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025 / MD 4158) 販売に関する免責事項
[ラテラルフローアッセイ(LFA)の世界市場予測(~2025):用途別、製品別、技術別、エンドユーザー別] ( Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025 / MD 4158) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆